These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4309848)

  • 21. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of herpes simplex virus infections].
    Ishak R; Pinheiro Fde P
    Rev Paul Med; 1982; 100(2):25-9. PubMed ID: 6763755
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up in herpes simplex virus encephalitis.
    Soto-Hernandez JL
    Clin Infect Dis; 2000 Jul; 31(1):206-7. PubMed ID: 10913431
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the clinical and experimental chemotherapy of virus infections].
    Rohde B; Hellmig HP
    Z Haut Geschlechtskr; 1967 Mar; 42(6):185-200. PubMed ID: 5582565
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
    Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
    J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):289-93. PubMed ID: 166611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Herpes simplex.
    Sklar SH
    Lancet; 1975 Sep; 2(7934):564. PubMed ID: 51398
    [No Abstract]   [Full Text] [Related]  

  • 30. [Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice].
    Kushch AA; Galegov GA; Klimova RR; Kozlov AIu; Litvin AA
    Antibiot Khimioter; 2008; 53(7-8):31-4. PubMed ID: 19227121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
    Cermak-Mörth CM; Christian R; Unger FM
    Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated glycyrrhizinic acid: significance against viral infections.
    Kukurtchu B
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():46-7. PubMed ID: 23236680
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
    Klein RJ; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 50 Years Ago in TheJournal ofPediatrics: In Utero Infection of the Fetus by Herpes Simplex Virus.
    Forster C
    J Pediatr; 2016 Jul; 174():164. PubMed ID: 27346508
    [No Abstract]   [Full Text] [Related]  

  • 35. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives.
    Baker DC; Haskell TH; Putt SR; Sloan BJ
    J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of kethoxal against cutaneous herpes simplex.
    Underwood GE; Nichol FR
    Appl Microbiol; 1971 Oct; 22(4):588-92. PubMed ID: 4331769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy of cutaneous herpesvirus infection of hairless mice.
    Lieberman M; Schafer TW; Came PE
    J Invest Dermatol; 1973 Apr; 60(4):203-6. PubMed ID: 4349225
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sensitization for tromantadine (Viru-Merz) in herpes simplex infections].
    van Ketel WG
    Ned Tijdschr Geneeskd; 1987 Mar; 131(11):461. PubMed ID: 3561555
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiviral effect of human gamma globulin in mice. Comparison between local and systemic administration].
    Akerfeldt S
    Lakartidningen; 1973 Oct; 70(41):3598-9. PubMed ID: 4132634
    [No Abstract]   [Full Text] [Related]  

  • 40. [Docosanol (Erazaban), dermal use].
    J Pharm Belg; 2011 Jun; (2):53-4. PubMed ID: 21823443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.